IL1B and type 2 diabetes mellitus: The vaccination of mice with IL-1β displayed on keyhole limpet hemocyanin (KLH) or VLPs has been shown to induce therapeutic antibodies for the treatment of RA [27,28] and type 2 diabetes [29], respectively.